Methotrexate remains one of the most widely used DMARDs for rheumatoid arthritis, forming the backbone of many treatment plans for autoimmune disease drugs and long‑term joint protection.
Used correctly, it can slow disease progression, reduce pain and swelling, and help many patients maintain daily function while clinicians monitor for potential methotrexate side effects in a structured way.
